http://orcid.org/0000-0002-2226-0239
Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Daniele Roberto Giacobbe, Jason A. Roberts, Mohd H. Abdul-Aziz, Etienne de Montmollin, Jean-François Timsit & Matteo Bassetti. (2022) Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective. Expert Review of Anti-infective Therapy 20:7, pages 963-979.
Read now
Read now
Filippo Del Puente, Daniele R. Giacobbe, Antonio Salsano, Alberto E. Maraolo, David S.Y. Ong, Erlangga Yusuf, Stefania Tutino, Anna Marchese, Francesco Santini & Claudio Viscoli. (2019) Epidemiology and outcome of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review. Journal of Chemotherapy 31:7-8, pages 359-366.
Read now
Read now
Daniele Roberto Giacobbe, Silvia Corcione, Antonio Salsano, Filippo Del Puente, Simone Mornese Pinna, Francesco Giuseppe De Rosa, Malgorzata Mikulska, Francesco Santini & Claudio Viscoli. (2019) Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery. Expert Opinion on Pharmacotherapy 20:6, pages 751-772.
Read now
Read now
Li Zhou, Shanglong Feng, Guangyu Sun, Baolin Tang, Xiaoyu Zhu, Kaidi Song, Xuhan Zhang, Huaiwei Lu, Huilan Liu, Zimin Sun & Changcheng Zheng. (2019) Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease. Infection and Drug Resistance 12, pages 481-491.
Read now
Read now
Ilias Karaiskos, Irene Galani, Maria Souli & Helen Giamarellou. (2019) Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens. Expert Opinion on Drug Metabolism & Toxicology 15:2, pages 133-149.
Read now
Read now
Daniele Roberto Giacobbe, Malgorzata Mikulska & Claudio Viscoli. (2018) Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria. Expert Review of Clinical Pharmacology 11:12, pages 1219-1236.
Read now
Read now
Articles from other publishers (23)
Marta Gómara-Lomero, Ana Isabel López-Calleja, Antonio Rezusta, José Antonio Aínsa & Santiago Ramón-García. (2023) In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae. Scientific Reports 13:1.
Crossref
Crossref
Danna R. Gifford, Ernesto Berríos-Caro, Christine Joerres, Marc Suñé, Jessica H. Forsyth, Anish Bhattacharyya, Tobias Galla & Christopher G. Knight. (2023) Mutators can drive the evolution of multi-resistance to antibiotics. PLOS Genetics 19:6, pages e1010791.
Crossref
Crossref
Bassel Awada, Dany Abi Chahine, Ghada Derbaj, Pascal Abdel Khalek, Mireille Kallassy Awad & Antoine Abou Fayad. (2023) Antimicrobial Natural Products Derived from Microorganisms Inhabiting the MENA Region. Natural Product Communications 18:2, pages 1934578X2311549.
Crossref
Crossref
Xinqian Ma, Shining Fu, Yifan Wang, Lili Zhao, Wenyi Yu, Yukun He, Wentao Ni & Zhancheng Gao. (2022) Proteomics Study of the Synergistic Killing of Tigecycline in Combination With Aminoglycosides Against Carbapenem-Resistant Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Inmaculada López Montesinos, Silvia Gómez-Zorrilla, Zaira Raquel Palacios-Baena, Nuria Prim, Daniel Echeverria-Esnal, María Pilar Gracia, María Milagro Montero, Xavier Durán-Jordà, Elena Sendra, Luisa Sorli, Roberto Guerri-Fernandez, Eduardo Padilla, Santiago Grau & Juan Pablo Horcajada. (2021) Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study. Infectious Diseases and Therapy 11:1, pages 335-350.
Crossref
Crossref
D. V. Tapalski & E. V. Karpova. (2021) Susceptibility to antibiotic combinations of <i>Klebsiella pneumoniae</i> and <i>Acinetobacter baumannii</i> strains isolated from COVID-19 patients. Health and Ecology Issues 18:4, pages 33-40.
Crossref
Crossref
B.W Carney, J A Rizzo, J F Alderete, R CindassJr.Jr., A E Markelz & L C Cancio. (2021) Carbapenem-Resistant Enterobacterales Infection After Massive Blast Injury: Use of Cefiderocol Based Combination Therapy. Military Medicine 186:11-12, pages 1241-1245.
Crossref
Crossref
Corneliu Ovidiu Vrancianu, Elena Georgiana Dobre, Irina Gheorghe, Ilda Barbu, Roxana Elena Cristian & Mariana Carmen Chifiriuc. (2021) Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections. Microorganisms 9:4, pages 730.
Crossref
Crossref
Rashin Namivandi-Zangeneh, Edgar H. H. Wong & Cyrille Boyer. (2021) Synthetic Antimicrobial Polymers in Combination Therapy: Tackling Antibiotic Resistance. ACS Infectious Diseases 7:2, pages 215-253.
Crossref
Crossref
I Karaiskos, G L Daikos, A Gkoufa, G Adamis, A Stefos, S Symbardi, G Chrysos, E Filiou, D Basoulis, E Mouloudi, L Galani, K Akinosoglou, K Arvaniti, A Masgala, M Petraki, E Papadimitriou, I Galani, G Poulakou, C Routsi, H Giamarellou, V Papoutsaki, H Papadogeorgaki, C Tsapas, M Astriti, V Romanou, E Makronassios, P Giona, K Pontikis, N Gatselis, E Massa, E Michailidou & C Gogos. (2021)
Ceftazidime/avibactam in the era of carbapenemase-producing
Klebsiella pneumoniae
: experience from a national registry study
. Journal of Antimicrobial Chemotherapy 76:3, pages 775-783.
Crossref
Crossref
John I. Hogan, Brandon K. Hill & Costi D. Sifri. 2021. Emerging Transplant Infections. Emerging Transplant Infections
343
370
.
Н.Ю. Лескова, Е.Г. Антонова, О.М. Акуленок, Е.В. Тимошкова, И.В. Жильцов & Д.В. Тапальский. (2020) Nosocomial Klebsiella pneumoniae infections: focus on using of antibiotics combinations. Клиническая инфектология и паразитология:3, pages 352-363.
Crossref
Crossref
Luciana Thomaz, Luiz Gustavo de Almeida, Flávia R. O. Silva, Mauro Cortez, Carlos P. Taborda & Beny Spira. (2020) In vivo Activity of Silver Nanoparticles Against Pseudomonas aeruginosa Infection in Galleria mellonella. Frontiers in Microbiology 11.
Crossref
Crossref
Junyan Qu, Rujia Yu, Qujue Wang, Chunlu Feng & Xiaoju Lv. (2020) Synergistic Antibacterial Activity of Combined Antimicrobials and the Clinical Outcome of Patients With Carbapenemase-Producing Acinetobacter baumannii Infection. Frontiers in Microbiology 11.
Crossref
Crossref
Geraldine J Sullivan, Natasha N Delgado, Ram Maharjan & Amy K Cain. (2020) How antibiotics work together: molecular mechanisms behind combination therapy. Current Opinion in Microbiology 57, pages 31-40.
Crossref
Crossref
Takashi Okanda & Tetsuya Matsumoto. (2020) In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPE. Journal of Infection and Chemotherapy 26:4, pages 322-330.
Crossref
Crossref
Indranil Samanta & Samiran Bandyopadhyay. 2020. Antimicrobial Resistance in Agriculture. Antimicrobial Resistance in Agriculture
97
105
.
John I. Hogan, Brandon K. Hill & Costi D. Sifri. 2020. Emerging Transplant Infections. Emerging Transplant Infections
1
29
.
Ilias Karaiskos, Styliani Lagou, Konstantinos Pontikis, Vasiliki Rapti & Garyphallia Poulakou. (2019) The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Frontiers in Public Health 7.
Crossref
Crossref
Jocelin Merida-Vieyra, Agustín De Colsa- Ranero, Patricia Arzate-Barbosa, Eduardo Arias- de la Garza, Alfonso Méndez-Tenorio, Jazmin Murcia-Garzón & Alejandra Aquino-Andrade. (2019) First clinical isolate of Escherichia coli harboring mcr-1 gene in Mexico. PLOS ONE 14:4, pages e0214648.
Crossref
Crossref
Zeinab JafariAhad Ali HaratiMehri HaeiliJalil Kardan-YamchiSirous JafariFereshteh JabalameliAlipasha MeysamieAlireza AbdollahiMohammad Mehdi Feizabadi. (2019)
Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant
Klebsiella pneumoniae
Isolates from Iran
. Microbial Drug Resistance 25:3, pages 336-343.
Crossref
Crossref
Mario Tumbarello, Angela Raffaella Losito & Helen Giamarellou. (2018) Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections. Current Opinion in Infectious Diseases 31:6, pages 566-577.
Crossref
Crossref
Piergiorgio Cojutti, Assunta Sartor, Matteo Bassetti, Claudio Scarparo & Federico Pea. (2018) Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?. Journal of Global Antimicrobial Resistance 14, pages 238-241.
Crossref
Crossref